Abelardo Aguilera

4.1k total citations · 1 hit paper
60 papers, 3.2k citations indexed

About

Abelardo Aguilera is a scholar working on Nephrology, Surgery and Physiology. According to data from OpenAlex, Abelardo Aguilera has authored 60 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Nephrology, 17 papers in Surgery and 9 papers in Physiology. Recurrent topics in Abelardo Aguilera's work include Dialysis and Renal Disease Management (33 papers), Parathyroid Disorders and Treatments (11 papers) and Muscle and Compartmental Disorders (8 papers). Abelardo Aguilera is often cited by papers focused on Dialysis and Renal Disease Management (33 papers), Parathyroid Disorders and Treatments (11 papers) and Muscle and Compartmental Disorders (8 papers). Abelardo Aguilera collaborates with scholars based in Spain, Sweden and Mexico. Abelardo Aguilera's co-authors include Rafael Selgas, M. Auxiliadora Bajo, Manuel López‐Cabrera, Gloria del Peso, José Antonio Sánchez-Tomero, José A. Jiménez‐Heffernan, Luiz Stark Aroeira, Marta Ramírez‐Huesca, Francisco Sánchez‐Madrid and Marı́a Yáñez-Mó and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Scientific Reports.

In The Last Decade

Abelardo Aguilera

60 papers receiving 3.1k citations

Hit Papers

Peritoneal Dialysis and Epithelial-to-Mesenchymal Transit... 2003 2026 2010 2018 2003 200 400 600

Peers

Abelardo Aguilera
Abelardo Aguilera
Citations per year, relative to Abelardo Aguilera Abelardo Aguilera (= 1×) peers Shuzo Kobayashi

Countries citing papers authored by Abelardo Aguilera

Since Specialization
Citations

This map shows the geographic impact of Abelardo Aguilera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abelardo Aguilera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abelardo Aguilera more than expected).

Fields of papers citing papers by Abelardo Aguilera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abelardo Aguilera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abelardo Aguilera. The network helps show where Abelardo Aguilera may publish in the future.

Co-authorship network of co-authors of Abelardo Aguilera

This figure shows the co-authorship network connecting the top 25 collaborators of Abelardo Aguilera. A scholar is included among the top collaborators of Abelardo Aguilera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abelardo Aguilera. Abelardo Aguilera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ávila-Carrasco, Lorena, Pedro Majano, José Antonio Sánchez-Tomero, et al.. (2019). Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition. Frontiers in Pharmacology. 10. 715–715. 160 indexed citations
2.
González, Sánchez, et al.. (2016). Enfermedad óseo mineral relacionada con la enfermedad renal crónica: Klotho y FGF23; implicaciones cardiovasculares. Nefrología. 36(4). 368–375. 13 indexed citations
3.
Gónzalez-Mateo, Guadalupe Tirma, Jesús Loureiro, Hugo Abensur, et al.. (2015). Rapamycin Protects from Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-MT. BioMed Research International. 2015. 1–15. 23 indexed citations
4.
Sandoval, Pilar, Jesús Loureiro, Guadalupe Tirma Gónzalez-Mateo, et al.. (2010). PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage. Laboratory Investigation. 90(10). 1517–1532. 54 indexed citations
5.
Jiménez‐Heffernan, José A., Cristian Perna, M. Auxiliadora Bajo, et al.. (2008). Tissue distribution of hyalinazing vasculopathy lesions in peritoneal dialysis patients. Pathology - Research and Practice. 204(8). 563–567. 6 indexed citations
6.
Aguilera, Abelardo, et al.. (2007). Effects of Tamoxifen on Epithelial-to-Mesenchymal Transition, Fibrosis, and Angiogenesis of Mesothelial Cells. Peritoneal Dialysis International. 27. 2 indexed citations
7.
Aguilera, Abelardo, José Antonio Sánchez-Tomero, & Rafael Selgas. (2007). Brain Activation in Uremic Anorexia. Journal of Renal Nutrition. 17(1). 57–61. 14 indexed citations
8.
Carrero, Juan Jesús, Abelardo Aguilera, Peter Stenvinkel, et al.. (2007). Appetite Disorders in Uremia. Journal of Renal Nutrition. 18(1). 107–113. 86 indexed citations
9.
Selgas, Rafael, José A. Jiménez‐Heffernan, José Antonio Sánchez-Tomero, et al.. (2006). Epithelial-to-mesenchymal transition of the mesothelial cell—its role in the response of the peritoneum to dialysis. Nephrology Dialysis Transplantation. 21(suppl_2). ii2–ii7. 92 indexed citations
10.
Díez, Juan J., Pedro Iglesias, María José Fernández‐Reyes, et al.. (2005). Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end‐stage renal disease. Clinical Endocrinology. 62(2). 242–249. 107 indexed citations
11.
Aroeira, Luiz Stark, Abelardo Aguilera, Rafael Selgas, et al.. (2005). Mesenchymal Conversion of Mesothelial Cells as a Mechanism Responsible for High Solute Transport Rate in Peritoneal Dialysis: Role of Vascular Endothelial Growth Factor. American Journal of Kidney Diseases. 46(5). 938–948. 165 indexed citations
12.
Díez, Juan J., María José Fernández‐Reyes, Rosa Codoceo, et al.. (2005). Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis. Clinical Endocrinology. 64(1). 68–73. 34 indexed citations
13.
Jiménez‐Heffernan, José A., Abelardo Aguilera, Luiz Stark Aroeira, et al.. (2004). Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 444(3). 247–256. 92 indexed citations
14.
Iglesias, Pedro, Juan J. Díez, María José Fernández‐Reyes, et al.. (2004). Growth hormone, IGF‐I and its binding proteins (IGFBP‐1 and ‐3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis. Clinical Endocrinology. 60(6). 741–749. 29 indexed citations
15.
Aguilera, Abelardo, Rosa Codoceo, M. Auxiliadora Bajo, et al.. (2004). Eating Behavior Disorders in Uremia: A Question of Balance in Appetite Regulation. Seminars in Dialysis. 17(1). 44–52. 49 indexed citations
16.
Yáñez-Mó, Marı́a, Enrique Lara‐Pezzi, Rafael Selgas, et al.. (2003). Peritoneal Dialysis and Epithelial-to-Mesenchymal Transition of Mesothelial Cells. New England Journal of Medicine. 348(5). 403–413. 640 indexed citations breakdown →
17.
Aguilera, Abelardo, M. Auxiliadora Bajo, Antonio Olveira, et al.. (2003). Gastrointestinal and pancreatic function in peritoneal dialysis patients: their relationship with malnutrition and peritoneal membrane abnormalities. American Journal of Kidney Diseases. 42(4). 787–796. 36 indexed citations
18.
Aguilera, Abelardo, et al.. (2000). Uremic Anorexia: A Consequence of Persistently High Brain Serotonin Levels? The Tryptophan/Serotonin Disorder Hypothesis. Peritoneal Dialysis International. 20(6). 810–816. 30 indexed citations
19.
Selgas, Rafael, M. Auxiliadora Bajo, Gloria del Peso, et al.. (1998). Stability of the Peritoneal Membrane in Long-Term Peritoneal Dialysis Patients. Advances in Renal Replacement Therapy. 5(3). 168–178. 20 indexed citations
20.
Lasunción, Miguel A., Maite Rivera, Abelardo Aguilera, et al.. (1997). Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients. American Journal of Kidney Diseases. 29(4). 569–575. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026